glp-1 peptide therapy Frontiers GLP-1 and GIP/GLP-1 Peptides Explained

Description

A new class action lawsuit alleges Hims & Hers falsely advertises its compounded GLP-1 semaglutide products as being the same as the weight loss and diabetes drugs Ozempic and Wegovy.

Pendulum, a research-based health company, has launched a groundbreaking new product - a probiotic supplement designed to naturally suppress appetite

Diabetes Technol...

Nausea and vomiting are common during the first weeks of semaglutide therapy, but several clinical strategies can help minimize these effects and keep you on track with weight loss

The Risks: Unknown ingredients and contamination Incorrect dosages and life-threatening side effects No regulatory oversight or safety data Why This Is Critical: Patients are bypassing pharmacies and getting injections from sketchy online vendors This undermines real GLP1 therapies and can lead to serious harm As healthcare professionals, we must: Ask patients about the source of their medications Report adverse reactions to MedWatch Educate our patients about safe access and real prescriptions Lets advocate for ethical prescribing and responsible patient care in the GLP1 era